Platform
Features
2 followers
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.
Industries
Headquarters
Employees
Links
Kenneth Galbraith
53 members
18 members
6 members
14 members
8 members
5 members
View all
Roivant Sciences
56 followers
Oxford Nanopore Technologies
6 followers
Novotech
4 followers
Arrowhead Pharmaceuticals
Axsome Therapeutics
BridgeBio
AbCellera
1 follower
PSC Biotech
MeiraGTx
Abzena
Alvotech
Explore companies